What is KRY?
Established in 2014 and headquartered in Stockholm, Sweden, KRY operates as a sophisticated digital health application. The platform facilitates immediate, secure consultations between patients and qualified healthcare professionals through smartphones and tablets. By bridging the gap between traditional clinical care and digital convenience, KRY has established itself as a critical component of the modern health tech ecosystem, effectively reducing barriers to medical access for a broad user base.
How much funding has KRY raised?
KRY has raised a total of $716.8M across 7 funding rounds:
Angel/Seed
$4.9M
Angel/Seed
$6.9M
Series A
$23M
Series B
$66M
Series C
$156M
Series D
$300M
Unspecified
$160M
Angel/Seed (2016): $4.9M, investors not publicly disclosed
Angel/Seed (2016): $6.9M led by Project A Ventures, Index Ventures, and Creandum
Series A (2017): $23M supported by Creandum, Index Ventures, and Accel
Series B (2018): $66M featuring Creandum, Accel, Project A Ventures, and Index Ventures
Series C (2020): $156M backed by Teachers Innovation Platform, Index Ventures, Creandum, and Accel
Series D (2021): $300M with participation from Accel, Fidelity, Index Ventures, CPP Investments, Ontario Teachers Pension Plan, Creandum, and Project A Ventures
Unspecified (2022): $160M led by Teachers’ Venture Growth and Index Ventures
Key Investors in KRY
Index Ventures
Index Ventures is a venture firm investing in the next generation of entrepreneurs from seed to IPO, partnering with founders who challenge the status quo to build enduring companies.
Creandum
Creandum is a leading European venture capital firm that supports successful technology companies, providing strategic advisory services from its offices in Stockholm, Berlin, and San Francisco.
Project A Ventures
Project A Ventures is a Berlin-based early-stage tech investor that combines capital with a platform team of functional experts to support startups in sectors like digital health and fintech.
What's next for KRY?
With the recent influx of capital, KRY is well-positioned to accelerate its product development and geographic footprint. The company is expected to leverage this financing to deepen its integration with existing healthcare systems and potentially expand its service offerings. As the digital health market continues to mature, KRY's focus will likely remain on maintaining high standards of clinical quality while scaling its operations to meet the increasing demand for remote medical services across Europe and beyond.
See full KRY company page
